BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20002097)

  • 1. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
    Becker KL; Snider R; Nylen ES
    Br J Pharmacol; 2010 Jan; 159(2):253-64. PubMed ID: 20002097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization.
    Snider RH; Nylen ES; Becker KL
    J Investig Med; 1997 Dec; 45(9):552-60. PubMed ID: 9444882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoneutralization of procalcitonin or its component peptides: a promising treatment of sepsis.
    Becker KL
    Clin Sci (Lond); 2010 Dec; 119(12):515-7. PubMed ID: 20649514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis.
    Martinez JM; Wagner KE; Snider RH; Nylen ES; Muller B; Sarani B; Becker KL; White JC
    Surg Infect (Larchmt); 2001; 2(3):193-202; discussion 202-3. PubMed ID: 12593709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.
    Becker KL; Snider R; Nylen ES
    Crit Care Med; 2008 Mar; 36(3):941-52. PubMed ID: 18431284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.
    Nylen ES; Whang KT; Snider RH; Steinwald PM; White JC; Becker KL
    Crit Care Med; 1998 Jun; 26(6):1001-6. PubMed ID: 9635646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of procalcitonin in critically ill trauma patients.
    Sakran JV; Michetti CP; Sheridan MJ; Richmond R; Waked T; Aldaghlas T; Rizzo A; Griffen M; Fakhry SM
    J Trauma Acute Care Surg; 2012 Aug; 73(2):413-8; discussion 418. PubMed ID: 22846948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoneutralization of procalcitonin as therapy of sepsis.
    Becker KL; Nylén ES; Snider RH; Müller B; White JC
    J Endotoxin Res; 2003; 9(6):367-74. PubMed ID: 14733723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin used as a marker of infection in the intensive care unit.
    Ugarte H; Silva E; Mercan D; De Mendonça A; Vincent JL
    Crit Care Med; 1999 Mar; 27(3):498-504. PubMed ID: 10199528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin for the clinical laboratory: a review.
    Schneider HG; Lam QT
    Pathology; 2007 Aug; 39(4):383-90. PubMed ID: 17676478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin and proinflammatory cytokine interactions in sepsis.
    Whang KT; Vath SD; Becker KL; Snider RH; Nylen ES; Muller B; Li Q; Tamarkin L; White JC
    Shock; 2000 Jul; 14(1):73-8. PubMed ID: 10909897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of procalcitonin in severe sepsis].
    Andrejaitiene J
    Medicina (Kaunas); 2006; 42(1):69-78. PubMed ID: 16467616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin in pediatrics.
    Pacifico L; Osborn JF; Natale F; Ferraro F; De Curtis M; Chiesa C
    Adv Clin Chem; 2013; 59():203-63. PubMed ID: 23461137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical usefulness of procalcitonin measurement].
    Kuroda S
    Kansenshogaku Zasshi; 2010 Jul; 84(4):437-40. PubMed ID: 20715553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
    Ittner L; Born W; Rau B; Steinbach G; Fischer JA
    Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum procalcitonin, but not C-reactive protein, identifies sepsis in trauma patients.
    Benoist JF; Mimoz O; Assicot M; Edouard A
    Clin Chem; 1998 Aug; 44(8 Pt 1):1778-9. PubMed ID: 9702980
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.
    Liu B; Chen YX; Yin Q; Zhao YZ; Li CS
    Crit Care; 2013 Oct; 17(5):R244. PubMed ID: 24138799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1.
    Gérard Y; Hober D; Assicot M; Alfandari S; Ajana F; Bourez JM; Chidiac C; Mouton Y; Bohuon C; Wattre P
    J Infect; 1997 Jul; 35(1):41-6. PubMed ID: 9279723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units].
    Průcha M; Herold I; Zazula R; Dubská L; Kavka B; Dostál M
    Vnitr Lek; 2003 Jul; 49(7):541-7. PubMed ID: 12931436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin as a diagnostic and prognostic marker for sepsis caused by intestinal infection: a case report.
    Liu YJ; Du P; Rao J
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1311-3. PubMed ID: 23740442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.